Weekly Sepsis Research Analysis
This week’s sepsis literature converged on three domains: mechanistic immunometabolism/epigenetics with actionable targets (e.g., GFAT–DRP1–calcium axis, histone lactylation/PAD4, TGFBI), randomized evidence refining resuscitation paradigms (TARTARE-2S showing no advantage for lower-MAP tissue-perfusion targeting but acceptable safety), and large-scale surveillance/diagnostic advances (regional AMR burden forecasts, high-performing EHR prediction models, and rapid point-of-care assays). Together
Summary
This week’s sepsis literature converged on three domains: mechanistic immunometabolism/epigenetics with actionable targets (e.g., GFAT–DRP1–calcium axis, histone lactylation/PAD4, TGFBI), randomized evidence refining resuscitation paradigms (TARTARE-2S showing no advantage for lower-MAP tissue-perfusion targeting but acceptable safety), and large-scale surveillance/diagnostic advances (regional AMR burden forecasts, high-performing EHR prediction models, and rapid point-of-care assays). Together these studies shift emphasis toward time-sensitive interventions, host-directed therapeutics, and improved diagnostic/stewardship infrastructure.
Selected Articles
1. Glutamine alleviates immunosuppression in polymicrobial sepsis by augmenting bacterial phagocytosis through sustaining the GFAT-DRP1 dependent mitochondrial calcium dynamics.
In murine polymicrobial sepsis models and complementary in vitro assays, glutamine supplementation restored macrophage bacterial phagocytosis, lowered bacterial burden, modulated cytokines, and improved survival. Mechanistically, glutamine activated a GFAT-dependent program that promoted DRP1 oligomerization (via O-GlcNAcylation) and CDK1-dependent DRP1 Ser616 phosphorylation, enhancing mitochondrial fission, mitochondrial Ca2+ efflux, and sustained cytosolic calcium needed for phagocytosis.
Impact: Identifies a novel, druggable immunometabolic axis (GFAT–DRP1–calcium) linking nutrient signaling to macrophage function with in vivo survival benefit, reframing glutamine from a nutritional supplement to a mechanistically supported adjunctive immunorestorative candidate.
Clinical Implications: Supports prioritized translational work: define timing/dose and safety of glutamine in immunosuppressed sepsis phenotypes, develop pharmacodynamic biomarkers (O-GlcNAcylation, DRP1 phosphorylation), and explore small-molecule modulators of GFAT/DRP1 in early-phase trials.
Key Findings
- Glutamine supplementation restored macrophage phagocytosis and improved survival in polymicrobial sepsis mice; benefits abrogated by macrophage depletion.
- Mechanism: GFAT-dependent O-GlcNAcylation drove DRP1 oligomerization and GFAT–CDK1 signaling induced DRP1 Ser616 phosphorylation, promoting mitochondrial fission and mitochondrial Ca2+ efflux to sustain cytosolic Ca2+ for phagocytosis.
- Provides in vivo and mechanistic evidence linking immunometabolism to host defense and identifies measurable pathway biomarkers.
2. Targeted Tissue Perfusion Versus Macrocirculatory-Guided Standard Care in Patients With Septic Shock: A Randomized Clinical Trial-The TARTARE-2S Trial.
In a multicenter randomized trial (n=219) of septic shock patients with lactate >3 mmol/L, a strategy targeting bedside tissue perfusion while allowing lower MAP (TTP) did not improve the primary outcome (30‑day days alive with normal lactate and without vasopressors/inotropes) compared with MAP-guided standard care. Mortality and organ-support–free days were similar and no excess safety signal emerged despite lower achieved MAP in the TTP arm.
Impact: Largest randomized test this week of a core resuscitation question—whether permissive lower MAP guided by perfusion indices improves outcomes—providing high-level evidence that outcome benefit was not observed and informing guideline deliberations.
Clinical Implications: Clinicians can incorporate peripheral perfusion measures (e.g., capillary refill) to tailor vasopressor intensity and avoid unnecessary high MAP targets when tissue perfusion is adequate, but routine adoption of a lower MAP target to improve outcomes is not supported by this trial alone.
Key Findings
- Primary composite outcome (30-day days alive with normal lactate and without vasoactives) showed no difference between TTP and standard care.
- 30-day mortality and organ-support–free days were comparable between arms; achieved MAP was lower in TTP but without excess safety events.
- Trial informs timing/targeting of vasopressor therapy and encourages integration of bedside perfusion indices.
3. The burden of bacterial antimicrobial resistance in the WHO Eastern Mediterranean Region 1990-2021: a cross-country systematic analysis with forecasts to 2050.
A multi-source modeling study estimated 380,000 AMR-associated deaths and 92,800 AMR-attributable deaths in the WHO Eastern Mediterranean Region in 2021, with six pathogens (including MRSA and major Gram-negatives) dominating burden and forecasts projecting substantial increases by 2050. The analysis highlights age and country heterogeneity and frames urgent priorities for surveillance, stewardship, and targeted interventions.
Impact: Delivers high-resolution, policy-relevant estimates and 2050 forecasts for regional AMR burden directly relevant to sepsis morbidity and mortality, guiding prioritization of stewardship, lab capacity building, and vaccination strategies in high-burden settings.
Clinical Implications: Health systems in the region should prioritize MRSA and Gram-negative control measures, expand microbiology capacity, and align stewardship/vaccination strategies to forecasted burden; globally, the study underscores the need to link AMR surveillance to sepsis care pathways.
Key Findings
- Estimated 380,000 AMR-associated and 92,800 AMR-attributable deaths in the EMR in 2021, with marked age and country heterogeneity.
- Six pathogens (S. pneumoniae, K. pneumoniae, E. coli, S. aureus, A. baumannii, P. aeruginosa) dominated burden; MRSA notable.
- Forecasts project large increases by 2050 (AMR-attributable deaths ≈187,000; AMR-associated ≈752,000), emphasizing urgent mitigation needs.